Publications

5539 Results

Acute myeloid leukemia (AML) with t(6;9)(p23;q34) defines a very poor risk leukemia subgroup with distinguishing clinicopathological features: a United States (US) cytogenetics Intergroup study of 62 AML and MDS cases.

Authors
ML Slovak;CD Bloomfield;H Gundacker;G Dewald;FR Appelbaum;RA Larson;MS Tallman;C Willman;Y Ravindranath;TA Alonzo;A Carroll;B Hirsch;S Raimondi;NA Heerema
Journal / Conference
Blood 104(11): #567
Year
2004
Research Committee(s)
Leukemia

Prognostic value of epidermal growth factor receptor expression and small cell phenotype in patients with glioblastoma treated with induction chemotherapy, radiotherapy, 0-6 benzylguanine

Authors
DT Blumenthal;M Quezado;M Santi;A Rapkiewicz;R Ronchetti;EJ Rushing
Journal / Conference
Neuro-Oncology 6(4):350 (PA-03)
Year
2004
Research Committee(s)
Brain
Study Number(s)
S0001

Clinical efficacy of high dose dexamethasone with maintenance dexamethasone/alpha interferon in patients with primary systemic amyloidosis: results of United States Intergroup trial Southwest Oncology Group (SWOG) S9628

Authors
MV Dhodapkar;MA Hussein;E Rasmussen;A Solomon;RA Larson;JJ Crowley;B Barlogie
Journal / Conference
Blood 104(12):3520-3526
Year
2004
Research Committee(s)
Myeloma
Study Number(s)
S9628

Genetic polymorphisms associated with clinical outcome in the Intergroup trial S9321, comparing high dose therapy with standard dose therapy for myelomaon, on behalf of ECOG, SWOG, CALGB, and the bank on a cure

Authors
R Santana-Davila;J Crowley;B Durie;B Barlogie;P Greipp;B Van Ness
Journal / Conference
Blood 104(11): #1495
Year
2004
Research Committee(s)
Myeloma
Study Number(s)
SWOG-9321

Comparable survival in newly diagnosed multiple myeloma (MM) after VAD induction with high dose therapy using melphalan 140mg/m2 + TBI 12 Gy (MEL + TBI) versus standard therapy with VBMCP and no benefit from interferon (IFN) maintenance: final clinical results of intergroup trial S9321 in the context of IFM 90 and MRC

Authors
J Crowley;R Fonseca;P Greipp;J McCoy;B Barlogie
Journal / Conference
Blood 104(11): #539
Year
2004
Research Committee(s)
Myeloma
Study Number(s)
SWOG-9321

N9741: Oxaliplatin (Oxal) + CPT-11 or 5-fluorouracil (5FU)/leucovorin (LV) in advanced colorectal cancer (CRC): final efficacy data from an intergroup study

Authors
RM Goldberg;RF Morton;DJ Sargent;CS Fuchs;RK Ramanathan;SK Williamson;BP Findley
Journal / Conference
ASCO Gastrointestinal Cancers Symposium #215
Year
2004
Research Committee(s)
Gastrointestinal
Study Number(s)
N9741

Microgranular variant (M3V) of acute promyelocytic leukemia (APL) does not have a worse prognosis than classical APL in the atra era: a report of 153 patients treated on Intergroup 0129 and pethema LPA96 and LPA99.

Authors
MS Tallman;HT Kim;CA Schiffer;FR Appelbaum;JH Feusner;AK Ogden;L Shepherd;CL Willman;CD Bloomfield;JM Rowe;RA Larson;PH Wiernik;G Martin;C Rayon;J de la Serna;C Rivas;JD Gonzalez-San Miguel;G Deben;MA Sanz
Journal / Conference
Blood 104(11): #394
Year
2004
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9129 (INT-0129)

LymphDx: a custom microarray for molecular diagnosis and prognosis in Non-Hodgkin lymphoma

Authors
SS Dave;G Wright;B Tan;A Rosenwald;WC Chan;TC Greiner;DD Weisenburger;JC Lynch;JM Vose;JO Armitage;RI Fisher;RM Braziel;LM Rimsza;TM Grogan;TP Miller;M LeBlanc;EB Smeland;S Kvaloy;H Holte;J Delabe;HK Muller-Hemelink;G Ott;RD Gascoyne;JM Connors;E Campo;E Montserrat;WH Wilson;ES Jaffe;TA Lister;AJ Davies;AJ Norton;R Simon;L Yang;J Powell;J Palma;J Warrington;H Zhao;M Chiorazzi;LM Staudt
Journal / Conference
Blood 104(11): #701
Year
2004
Research Committee(s)
Lymphoma

Concurrent (CAFT) versus sequential (CAF-T) chemohormonal therapy (cyclophosphamide, doxorubicin, 5-fluorouracil, tamoxifen) versus T alone for postmenopausal, node-positive, estrogen (ER) and/or progesterone (PgR) receptor-positive breast cancer: mature outcomes and new biologic correlates on phase III intergroup trial 0100 (SWOG-8814)

Authors
K Albain;W Barlow;F O'Malley;K Siziopikou;IT Yeh;P Ravdin;D Lew;W Farrar;G Burton;S Ketchel;C Cobau;E Levine;J Ingle;K Pritchard;A Lichter;D Schneider;M Abeloff;IC Henderson;L Norton;D Hayes;S Green;R Livingston;S Martino;CK Osborne;DC Allred
Journal / Conference
SABCS, late acceptance:#37, http://www.abstracts2view.com/sabcs/sessionindex.php
Year
2004
Research Committee(s)
Breast
Study Number(s)
SWOG-8814

Prostate cancer chemoprevention: an overview of United States trials

Authors
A Barqawi;IM Thompson;ED Crawford
Journal / Conference
Journal of Urology 171:S5-S9
Year
2004
Research Committee(s)
Cancer Control and Prevention and Epidemiology
Study Number(s)
S0000, SWOG-9217